Table 1.
Countries with the most vaccine research and/or the greatest numbers of vaccine registrations [8].
| Country | Vaccine Trials |
Approved Vaccines |
Vaccines |
|---|---|---|---|
| Argentina | 18 | 9 | mRNA-1273, BNT162b2, Ad5-nCoV, Sputnik Light, Sputnik V, AZD1222 (Vaxzevria + Covishield), BBIBP-CorV, and COVID-19 Vaccine (Vero Cell) |
| Australia | 31 | 5 | NVX-CoV2373, mRNA-1273, mRNA-1273.214, BNT162b2, Ad26.COV2.S, and AZD1222 |
| Belgium | 19 | 6 | NVX-CoV2373, mRNA-1273, mRNA-1273.214, BNT162b2, BNT162b2 (B.1.1.529), BNT162b2 Bivalent, Ad26.COV2.S, AZD1222, and VLA2001 |
| Brazil | 32 | 7 | BNT162b2, Sputnik V, Ad26.COV2.S, AZD1222 (Vaxzevria + Covishield), BBIBP-CorV, and COVID-19 Vaccine (Vero Cell) |
| Canada | 25 | 8 | NVX-CoV2373, Covifenz, mRNA-1273, mRNA-1273.214, BNT162b2, Ad26.COV2.S, and AZD1222 (Vaxzevria + Covishield) |
| China | 98 | 8 | Zifivax, V-01, Ad5-nCoV-IH, Ad5-nCoV, KCONVAC, BBIBP-CorV, and COVID-19 Vaccine (Vero Cell) (Inactivated (Vero Cells) + CoronaVac) |
| Germany | 31 | 9 | NVX-CoV2373, mRNA-1273, mRNA-1273.214, BNT162b2 (B.1.1.529), BNT162b2 Bivalent, Ad26.COV2.S, AZD1222, and VLA2001 |
| India | 36 | 12 | NVX-COV2373, Corbevax, ZyCoV-D, GEMCOVAC-19, mRNA-1273, iNCOVACC, Sputnik Light, Sputnik V, Ad26.COV2.S, AZD1222 (Vaxzevria + Covishield), and BBV152 |
| Indonesia | 22 | 13 | Zifivax, IndoVac, NVX-COV2373, mRNA-1273, BNT162b2, AWcorna, Ad5-nCoV, Sputnik V, Ad26.COV2.S, AZD1222, KCONVAC, BBIBP-CorV, and COVID-19 Vaccine (Vero Cell) |
| Islamic Republic of Iran | 26 | 12 | Noora vaccine, Soberana 02, Razi Cov Pars, SpikoGen, Sputnik Light, Sputnik V, Ad26.COV2.S, AZD1222, BBV152, FAKHRAVAC (MIVAC), COVIran Barekat, and BBIBP-CorV |
| Japan | 44 | 7 | TAK-019, mRNA-1273.214, BNT162b2, BNT162b2 (B.1.1.529), BNT162b2 Bivalent, TAK-919, and AZD1222 |
| Philippines | 22 | 11 | NVX-CoV2373, BNT162b2, mRNA-1273, Sputnik Light, Sputnik V, Ad26.COV2.S, AZD1222, BBV152, BBIBP-CorV, and COVID-19 Vaccine (Vero Cell) (Inactivated (Vero Cells) + CoronaVac) |
| Republic of Korea | 22 | 8 | NVX-CoV2373, SKYCovione, mRNA-1273, mRNA-1273.214, BNT162b2, BNT162b2 (B.1.1.529), Ad26.COV2.S, and AZD1222 |
| Russia | 33 | 6 | Aurora-CoV, EpiVacCorona, Gam-COVID-Vac, Sputnik Light, Sputnik V, and KoviVac |
| South Africa | 26 | 6 | NVX-COV2373, BNT162b2, Ad26.COV2.S, AZD1222, BBIBP-CorV, and COVID-19 Vaccine (Vero Cell) |
| Spain | 22 | 9 | NVX-CoV2373, mRNA-1273, mRNA-1273.214, BNT162b2, BNT162b2 (B.1.1.529), BNT162b2 Bivalent, Ad26.COV2.S, AZD1222, and VLA2001 |
| Thailand | 22 | 7 | NVX-COV2373, mRNA-1273, BNT162b2, Ad26.COV2.S, AZD1222, BBIBP-CorV, and COVID-19 Vaccine (Vero Cell) |
| United Kingdom of Great Britain and Northern Ireland | 29 | 8 | NVX-CoV2373, mRNA-1273, mRNA-1273.214, BNT162b2, BNT162b2 (B.1.1.529), Ad26.COV2.S, AZD1222, and VLA2001 |
| United States of America | 109 | 6 | NVX-CoV2373, mRNA-1273, mRNA-1273.214, BNT162b2 Bivalent, and Ad26.COV2.S |